超声引导下甲状腺囊内注射地塞米松与利多卡因混合液治疗亚急性甲状腺炎的单中心研究
该单中心研究将73例亚急性甲状腺炎患者分为超声引导下甲状腺病灶区囊内注射地塞米松与利多卡因组(48例)和口服泼尼松龙组(25例),随访1年。结果显示注射组疼痛缓解时间、治疗时长及甲状腺功能恢复时间均显著短于口服组(P<.05),复发率与甲减发生率无显著差异(P>.05),但注射组治疗结束时体重增加更明显(P<.001)。结论认为超声引导下局部注射安全有效,可显著缩短治疗时间。
要点
- 超声引导下甲状腺囊内注射地塞米松与利多卡因可缩短亚急性甲状腺炎疼痛缓解及治疗时间。
- 注射组与口服泼尼松龙组在复发率和甲减发生率上无显著差异。
- 注射组治疗结束时体重增加较口服组更明显,需关注激素相关副作用。
关键影像表现/征象
- A组疼痛缓解持续时间、治疗持续时间及甲状腺功能恢复时间均显著短于B组(P<.05)。
- A组与B组在复发率和甲减发生率上无统计学显著差异(P>.05)。
- A组治疗结束时体重增加显著高于B组(P<.001)。
临床应用与阅片要点
- 超声引导下可将地塞米松与利多卡因混合液精准注入甲状腺病灶区域囊内,作为亚急性甲状腺炎局部治疗方式。
- 注射治疗可缩短疼痛缓解和甲状腺功能恢复时间,但需监测体重增加等激素相关副作用。
局限性
- 单中心研究,样本量有限(A组48例、B组25例),组间样本量不平衡。
- 原文未报告随机化方法与盲法设计。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Subacute thyroiditis (SAT) is a self-limiting, inflammatory thyroid disease possibly caused by viral infection. In recent years, the incidence of SAT is increasing, especially during the pandemic of the COVID-19. This study aimed to evaluate the efficacy, safety, and recovery time of capsular thyroid injection therapy under ultrasound guidance for SAT.
METHODS: A total of 73 patients with SAT were divided into two groups. Patients in group A (n = 48) received an ultrasound-guided capsular injection consisting of dexamethasone (DEX) and lidocaine in the thyroid lesion area, while patients in group B (n = 25) received oral prednisolone (PSL). The two groups were compared for pain relief and treatment duration, the recovery time of thyroid function, recurrence rates, hypothyroidism incidence, and drug-related side effects.
RESULTS: The follow-up time was 1 year. In group A, the duration of pain relief, treatment, and recovery time of thyroid function were significantly shorter than that in group B (P < .05), and no statistically significant differences in recurrence rate or incidence of hypothyroidism were observed (P > .05). Weight gain was significantly higher in group A at the end of treatment (P < .001).
CONCLUSIONS: Compared with oral PSL treatment, ultrasound-guided local injection of DEX and lidocaine into the capsular thyroid is a safe and effective procedure that can significantly reduce the treatment time of SAT.
引用
- Huo, Chen, Gao, et al. Ultrasound-Guided Capsular Thyroid Injection Therapy With Dexamethasone and Lidocaine Mixture for Subacute Thyroiditis: A Single-Center Study. J Ultrasound Med. 2022. PMID: 36056908. doi:10.1002/jum.16054
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。